RightFit
RecruitingNot applicable

Finding Immune Nascent Type 1 Diabetes

Finding Immune Nascent Type 1 Diabetes (FIND T1D)

Who can join

As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.

Age
1 Year to 99 Years
Sex
All sexes
Healthy volunteers
Accepted
Compensation
Not stated

Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.

What to expect

No one can promise a trial will help you personally — that is what the research is trying to find out.

What participation involves

Not stated in the study description — ask the study team about visits and procedures.

Compensation
Not stated
  • Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
  • Participants are monitored closely by the research team throughout the study.
  • Some participants may receive access to an investigational treatment, which is still being studied.
  • Your participation helps researchers learn whether this approach could help future patients.

About this study

In plain language

This study tests which way of contacting people leads to more returned home screening kits for type 1 diabetes. Researchers will compare email or mail with phone calls and follow-up by a study team member. The study is for people ages 1–99 who are in the Indiana Biobank.

The goal of this clinical trial is to understand how many individuals who previously participated in the Indiana Biobank will return a type 1 diabetes home screening kit based upon different methods of recruitment communication. The main question it aims to answer is: What form of recruitment communication is most effective for completing a type 1diabetes home screening kit? Researchers will compare two types of recruitment contact: email and mail based communication (low-touch) versus phone contact and follow-up by a research team member (high-touch). Participants will be contacted either via email/mail or by phone and asked if they want to complete a type 1 diabetes home screening kit.

Compensation is read from the study's own description and may be missing — always confirm with the study team.

Eligibility

Who can join

  • Must be in the Indiana Biobank.
  • Must be able to give consent, or permission to take part.
  • Must be ages 1–99. Pregnant women can take part.

Who can't join

  • People who refuse to sign the consent form cannot take part in home screening.
  • People already diagnosed with diabetes cannot do the home test for autoantibodies, which are immune proteins that can attack the body's own cells. Other medical conditions are allowed.

Simplified for readability. The official criteria below are what the study team uses.

Official eligibility criteria

Inclusion Criteria: * Participant must be in Indiana Biobank * Participant must be able to provide consent * Ages 1-99 including pregnant women Exclusion Criteria: * Refusal to sign informed consent for home screening is exclusionary for the home screening portion of the study * While other medical conditions are allowable prior diabetes diagnosis is exclusionary for home autoantibody screening

Study sites (1)

IN